Assessing the Accuracy of the RevK Sensor
Completed
- Conditions
- Patients Undergoing Spine Surgery
- Registration Number
- NCT01877876
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.
- Detailed Description
Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
- Male or non-pregnant female
- American Society of Anesthesiology Classification 1, 2 or 3
- Scheduled to undergo spine or hip surgery
Read More
Exclusion Criteria
- Pregnant or nursing
- Patients who in the study investigators clinical judgement would not be suitable for research
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the accuracy of the RevK sensor for measuring blood hemoglobin compared to a laboratory-derived hemoglobin value. Intermittently during spine surgery Primary outcome is based on the difference between a value from the SpHb (Masimo SpHb™ continuous hemoglobin reading) minus tHb (laboratory hemoglobin determination).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States